Abstract

CURRENT SCENARIO ON USE OF ISOTRETINOIN IN VARIOUS FORMS OF ACNE

Dr. Nalini Negi*, Dr. Sumir Kumar, Sourabh Kosey and Tarun Gautam

Abstract

Acne is estimated to affect 9.4% of the population globally in which it is commonly seen in post pubescent teens, predominantly in males.[1] Across gender females (56%) showed significantly higher prevalence than males (51.6%), alongside males showing higher incidence than females in onset of disease at younger age. In case of mild acne condition females significantly showed higher prevalence than males, while in case of moderate and severe condition it was observed to be common in males than females.[2] To paramount the prevalence and severity of acne vulgaris in adolescents, a cross-sectional, study was performed that was community-based. In it, 1,002 people with an age of 16±0.9 years were volunteered. In the study the prevalence rate was 93.3; 94.4% and 92.0% for boys and girls respectively among which 14% of the members had moderate to severe acne. Here, the prevalence of moderate to severe acne was 19.9% in those with and 9.8% in those without a family history of acne (P

Keywords: Isotretinoin, teratogenic, acne, retinoids, iPLEDGE.